Azithromycin in posttransplant bronchiolitis obliterans syndrome

Chest

Volumn 139, Issue 5, 2011, Pages 1246-

  Vos, Robin ^a   Vanaudenaerde, Bart M ^a   Verleden, Stijn E ^a   Van Raemdonck, Dirk E ^a   Dupont, Lieven J ^a   Verleden, Geert M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; PLACEBO;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BRONCHIOLITIS OBLITERANS; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; HUMAN; INNATE IMMUNITY; LETTER; LOW DRUG DOSE; LUNG TRANSPLANTATION; NEUTROPHILIA; OVERALL SURVIVAL; POSTTRANSPLANT BRONCHIOLITIS OBLITERANS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFLAMMATION; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 79955765692     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2944     Document Type: Letter

References (6)

1. Friedlander AL, Albert RK. Chronic macrolide therapy in inflammatory airways diseases. Chest. 2010;138(5):1202-1212.
2. Vos R, Vanaudenaerde BM, Ottevaere A, et al. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer? J Heart Lung Transplant. 2010;29(12):1358-1368.
3. Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2008;85(1):36-41.
4. Jain R, Hachem RR, Morrell MR, et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant. 2010;29(5):531-537.
5. Vos R, Vanaudenaerde BM, Verleden SE, et al. A randomized placebo-controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J. 2011;37(1):164-172.
6. Hickey AJ, Lu D, Ashley ED, Stout J. Inhaled azithromycin therapy. J Aerosol Med. 2006;19(1):54-60.